IRODALOM
1. Ammann R.W., Muellhaupt B. et al.: The natural
history of pain in alcoholic chronic pancreatitis.
Gastroenterol., 1999, 116, 1132-1140.
2. Apte M.V., Haber P.S. et al.: Pancreatic stellate cells
are activated by proinflammatory cytokines:
implications for pancreatic fibrogenesis. Gut, 1999, 44,
534-541.
3. Bachem M.G., Schneider E. et al.: Identification,
culture and characterization of pancreatic stellate cells
in rats and humans. Gastroenterol., 1998, 115, 421-432.
4. Berney T., Gasche Z. et al.: Serum profiles of IL-6,
IL-8 and IL-10 in patients with severe and mild acute
pancreatitis. Pancreas, 1999, 8, 371-377.
5. Cohn J.A., Friedman K.J. et al.: Relation between
mutations of the cystic fibrosis gene and idiopathic
pancreatitis. N. Engl. J. Med., 1998, 339, 653-658.
6. Cohn J.A., Jowell P.S.: Are mutations in the cystic
fibrosis gene important in chronic pancreatitis. Surg.
Clin. North Am., 1999, 79, 723-734.
7. Corazziari E., Shaffer E.A. et al.: Functional
disorders of the biliary tract and pancreas. Gut, 1999,
45 (Suppl. II), 48-54.
8. Dervenis C., Johnson C.D. et al.: Diagnosis,
objective assessment of severity, and management of
acute pancreatitis. Int. J. Pancreatol., 1999, 25,
195-210.
9. DiFrancesco V., Brunori M.P. et al.: Comparison of
ultrasound-secretin test and sphincter of Oddi
manometry in patients with recurrent acute pancreatitis.
Dig. Dis. Sci., 1999, 44, 336-340.
10. DiMagno E.P.: Toward understanding (and
management) of painful chronic pancreatitis.
Gastroenterol., 1999, 116, 1252-1257.
11. Frossard J.L., Saluja A. et al.: The role of
intercellular adhesion molecule-1 and neutrophils in
acute pancreatitis and pancreatitis-associated lung
injury. Gastroenterol., 1999, 116, 694-701.
12. Gates L.K., Ulrich C.D. et al.: Hereditary
pancreatitis. Surg. Clin. North. Am., 1999, 79:,
711-720.
13. Gorry M.C., Gabbaizedeh D. et al.: Mutations in the
cationic trypsinogen gene are associated with recurrent
acute and chronic pancreatitis. Gastroenterol., 1999,
113, 1063-1068.
14. Greenberg R., Haddad R. et al.: Continuous
intravenous octreotide treatment for acute experimental
pancreatitis. Digestion , 1999, 60, 125-131.
15. Gress F., Schmitt C. et al.: A prospective
randomized comparison of endoscopic ultrasound- and
computed tomography-guided celiac plexus block for
managing chronic pancreatitis pain. Am. J.
Gastroenterol., 1999, 94, 900-905.
16. Grisham M.B.: NF-B activation in acute
pancreatitis: protective, detrimental, or inconsequential.
Gastroenterol., 1999, 116, 489-492.
17. Hruban R.H., Goggins M. et al.: Molecular genetics
and related developments in pancreatic cancer. Curr.
Op. Gastroenterol., 1999, 15, 404-409.
18. Imrie C.W., Menezes N. et al.: Diagnosis of chronic
pancreatitis and newer aspects of pain control.
Digestion, 1999, 60(Suppl.1), 111-113.
19. Isaji S., Hayashi J. et al.: Effects of IS-741 (a new
synthetic antiinflammatory agent) on acute necrotizing
pancreatitis in dogs. Digestion, 1999, 60 (Suppl.1),
47-51.
20. Jaffe E.M., Schutte M. et al.: Development and
characterization of a cytokin-secreting pancreatic
adenocarcinoma vaccine from primary tumors for use
in clinical trials. Cancer J. Sci. Am., 1998, 4, 194-203.
21. Jaffe E.M.: A phase I clinical trial of lethally
irradiated allogeneic pancreatic tumor cells transfected
with the GM-CSF gene for the treatment of pancreatic
adenocarcinoma. Hum. Gene Ther., 1998, 9, 978-985.
22. Johnson C.D.: Platelet-activating factor and
platelet-activating factor antagonists in acute
pancreatitis. Dig. Surg., 1999, 16, 93-101.
23. Kanwar S.: Early enteral nutrition in acute
pancreatitis. Nutrition, 1999, 15, 951-952
24. Karolinska Institute Press Release, 1999:
http://www. nobel. se/ announcement-99/ medicine 99.
html.
25. Kaufmann P., Smolle K.H. et al.: Relation of serial
measurements of plasma-soluble intercellular adhesion
molecule-1 to severity of acute pancreatitis. Am. J.
Gastroenterol., 1999, 94, 2412-2416.
26. Kita K., Saito S. et al.: Growth inhibition of human
pancreatic cancer cell lines by anti-sense
oligonucleotides specific to mutated k-ras genes. Int. J.
Cancer., 1999, 80, 553-558.
27. Liang J., Yamaguchi Y. et al.: Novel carboxamide
derivative (IS-741) attenuates lung injury in rats with
cerulein-induced pancreatitis complicated by
endotoxaemia. Dig. Dis. Sci., 1999, 44, 341-349.
28. MacFie J., O,Boyle C. et al.: Gut origin of sepsis: a
prospective study investigating associations between
bacterial translocation, gastric microflora, and septic
morbidity. Gut, 1999, 45, 223-228.
29. McKenzie I.F.C., Apostolopoulos V.: Towards
immunotherapy of pancreatic cancer. Gut, 1999, 44,
767-769.
30. Pemberton L.F., Blobel G. et al.: Transport routes
through the nuclear pore complex. Curr. Opn. Cell
Biol., 1998, 10, 392-399.
31. Pezzilli R., Miniero R. et al.: Behavior of serum
interleukin 12 in human acute pancreatitis. Pancreas,
1999, 18, 247-251.
32. Saluja A.K., Steer M.L.: Pathophysiology of
pancreatitis. Digestion, 1999, 60 (Suppl.1): 27-33.
33. Satoh A., Shimosegawa T. et al.: Inhibition of
nuclear factor activation improves the survival of rats
with taurocholate pancreatitis. Gut, 1999, 44, 253-258.
34. Schmid S.W., Uhl W. et al.: The role of infection
in acute pancreatitis. Gut, 1999, 45, 311-316.
35. Sharer N., Schwarz M. et al.: Mutations of the
cystic fibrosis gene in patients with chronic pancreatitis.
N. Engl. J. Med., 1998, 339, 645-652.
36. Steinle A.U., Weidenbach H. et al.: NFB/Rel
activation in cerulein pancreatitis. Gastroenterol., 1999,
116, 420-430.
37. Suzuki A., Mizumoto A. et al.: Effect of bacterial or
porcine lipase with low- or high-fat diets on nutrient
absorption in pancreatic-insufficient dogs.
Gastroenterol., 1999, 116, 431-437.
38. Talamini G., Bassi C. et al.: Alcohol and smoking
as risk factors in chronic pancreatitis and pancreatic
cancer. Dig. Dis. Sci., 1999, 44, 1303-1311.
39. Talamini G., Falconi M. et al.: Incidence of cancer
in the course of chronic pancreatitis. Am. J.
Gastroenterol., 1999, 94, 1253-1260.
40. Teich N., Mössner J. et al.: Screening for mutations
of the cationic trypsinogen gene: are they of relevance
in chronic alcoholic pancreatitis. Gut, 1999, 44,
413-416.
41. Uhl W., Büchler M.W. et al.: A randomised, double
blind, multicentre trial of octreotide in moderate to
severe pancreatitis. Gut, 1999, 45, 97-104.
42. Vaquero E., Molero X. et al.: Myelofibroblast
proliferation, fibrosis, and defective pancreatic repair
induced by cyclosporin in rats. Gut, 1999, 45, 269-277.
43. Whitcomb D.C: Early trypsinogen activation in
acute pancreatitis. Gastroenterol., 1999, 116, 770-772.
